Sort
64,565 grants matching “drug discovery”
Sphingolipids, Diabetes, and Cardiovascular Disease
$534,613Rozenn Lemaitre · University Of Washington · R01 · FY2015 · DK
INTEGRATIVE MODEL OF SUBCELL PROCESSES: APPL TO SYNAPTIC ACT & PHARM DISCOVERY
$534,591James A McCammon · University Of California, San Diego · P41 · FY2007 · RR
Genetic and Molecular Basis of Longevity
$534,502Gary B. Ruvkun · Massachusetts General Hospital · R01 · FY2011 · AG
Selective Inhibitors of Pro-Ferroptotic Lipoxygenases - Next Generation Radiomitigators
$534,477Valerian E Kagan · University Of Pittsburgh At Pittsburgh · U01 · FY2021 · AI
Training in Pharmacological Sciences
$534,450David E. Golan · Harvard Medical School · T32 · FY2025 · GM
Symbiosis and Chemical Diversity Generation
$534,448Eric W Schmidt · University Of Utah · R35 · FY2018 · GM
Discovery of 12/15-lipoxygenase therapeutics for Alzheimer's disease
$534,417Theodore R Holman · University Of California Santa Cruz · R01 · FY2022 · AG
Molecular Pathways of Pain Generation in Osteoarthritis
$534,402Anne-Marie Malfait · Rush University Medical Center · R01 · FY2025 · AR
Rational Design of antivrials targeted to HIV-1 capsid
$534,400Asim K Debnath · New York Blood Center · R01 · FY2010 · AI
Drug Discovery and Development
$534,392Paul D. Robbins · Mayo Clinic Rochester · P01 · FY2023 · AG
Mechanisms of DNA and RNA transactions
$534,384Stewart H Shuman · Sloan-Kettering Inst Can Research · R35 · FY2018 · GM
Large-Scale Discovery of Functional Genetic Variation in Rhesus Macaques
$534,371Jeffrey A Rogers · Baylor College Of Medicine · R24 · FY2014 · OD
Targeting Integrin Signaling in Atherosclerosis
$534,347Darren G Woodside · Texas Heart Institute · R33 · FY2025 · HL
Inhibition of hepatic (V)LDL production by a novel antagonist of carboxyl esterase 1
$534,330Stephen A Duncan · Medical University Of South Carolina · R01 · FY2025 · DK
Coupling Epitranscriptomics to Molecular Disease Mechanisms and Nucleic Acid Therapeutics in Persistent Residual HIV Infection
$534,319Keith Thomas Gagnon · Wake Forest University Health Sciences · R61 · FY2024 · AI
Clinical Pharmacology, Drug Action and Pharmacogenetics
$534,314Radojka Savic · University Of California, San Francisco · T32 · FY2024 · GM
Intervention Core for the Dietary Biomarkers Development Center at Harvard University
$534,194Frank M Sacks · Harvard School Of Public Health · U2C · FY2021 · DK
HTS for Direct Targeting of the Transcription Factor MITF
$534,190Thomas J. Kodadek · Scripps Florida · R01 · FY2016 · CA
APOBEC3 STRUCTURAL STUDIES
$534,174Reuben S Harris · University Of Minnesota · R01 · FY2019 · GM
Discovery and development of novel glycine transporter-2 inhibitors for the treatment of neuropathic pain
$534,125Christopher L. Cioffi · Albany College Of Pharmacy · R01 · FY2019 · DA
Resources for Teleost Gene Duplicates and Human Disease
$534,097John Harvey Postlethwait · University Of Oregon · R01 · FY2006 · RR
Drosophila Genomics Resource Center
$534,063Peter T Cherbas · Trustees Of Indiana University · P40 · FY2014 · OD
Resource to Advance Pediatrics and HIV Prevention Science (RAPPS): Quality Assurance/Quality Control (QA/QC) Support
$534,007Peter Silvera · Advanced Bioscience Laboratories, Inc. · N01 · FY2024 · AI
Effect of inflammation on JAK2 mutant evolution in the hematopoietic system: mathematical models and experiments
$533,981Angela Goffredo Fleischman · University Of California-Irvine · R37 · FY2023 · CA
Structural Analysis of Macromolecular Assemblies
$533,969Joachim Frank · Columbia University Health Sciences · R01 · FY2016 · GM